Pancreatic cancer, Secondary cancers
Open
Phase 2
This trial is looking at adding a new drug called ginisortamab to chemotherapy for pancreatic cancer that has spread to other parts of the body. It is also looking at ginisortamab in combination with another drug called cobimetinib after chemotherapy.
It is for people who haven’t yet had treatment for advanced pancreatic cancer.
You pronounce ginisortamab as gin-ee-saw-ta-mab.
Cancer Research UK supports this trial.
Recruitment start: 23 April 2024
Recruitment end: 31 October 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Cancer Research UK (Centre for Drug Development)
UCB Biopharma SRL
This is Cancer Research UK trial number CRUKD/24/002.
Last reviewed: 07 Apr 2026
CRUK internal database number: 19221
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
